Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 52(8): 4234-4256, 2024 May 08.
Article in English | MEDLINE | ID: mdl-38348998

ABSTRACT

Mammalian promoters consist of multifarious elements, which make them unique and support the selection of the proper transcript variants required under diverse conditions in distinct cell types. However, their direct DNA-transcription factor (TF) interactions are mostly unidentified. Murine bone marrow-derived macrophages (BMDMs) are a widely used model for studying gene expression regulation. Thus, this model serves as a rich source of various next-generation sequencing data sets, including a large number of TF cistromes. By processing and integrating the available cistromic, epigenomic and transcriptomic data from BMDMs, we characterized the macrophage-specific direct DNA-TF interactions, with a particular emphasis on those specific for promoters. Whilst active promoters are enriched for certain types of typically methylatable elements, more than half of them contain non-methylatable and prototypically promoter-distal elements. In addition, circa 14% of promoters-including that of Csf1r-are composed exclusively of 'distal' elements that provide cell type-specific gene regulation by specialized TFs. Similar to CG-rich promoters, these also contain methylatable CG sites that are demethylated in a significant portion and show high polymerase activity. We conclude that this unusual class of promoters regulates cell type-specific gene expression in macrophages, and such a mechanism might exist in other cell types too.


Subject(s)
Cell Lineage , Gene Expression Regulation , Macrophages , Promoter Regions, Genetic , Transcription Factors , Animals , Mice , DNA Methylation , Macrophages/metabolism , Transcription Factors/metabolism , Transcription Factors/genetics
2.
Immunity ; 55(11): 2006-2026.e6, 2022 11 08.
Article in English | MEDLINE | ID: mdl-36323312

ABSTRACT

Prior exposure to microenvironmental signals could fundamentally change the response of macrophages to subsequent stimuli. It is believed that T helper-2 (Th2)-cell-type cytokine interleukin-4 (IL-4) and Toll-like receptor (TLR) ligand-activated transcriptional programs mutually antagonize each other, and no remarkable convergence has been identified between them. In contrast, here, we show that IL-4-polarized macrophages established a hyperinflammatory gene expression program upon lipopolysaccharide (LPS) exposure. This phenomenon, which we termed extended synergy, was supported by IL-4-directed epigenomic remodeling, LPS-activated NF-κB-p65 cistrome expansion, and increased enhancer activity. The EGR2 transcription factor contributed to the extended synergy in a macrophage-subtype-specific manner. Consequently, the previously alternatively polarized macrophages produced increased amounts of immune-modulatory factors both in vitro and in vivo in a murine Th2 cell-type airway inflammation model upon LPS exposure. Our findings establish that IL-4-induced epigenetic reprogramming is responsible for the development of inflammatory hyperresponsiveness to TLR activation and contributes to lung pathologies.


Subject(s)
Interleukin-4 , Lipopolysaccharides , Mice , Animals , Interleukin-4/metabolism , Lipopolysaccharides/metabolism , Ligands , Epigenomics , Macrophages/metabolism , Toll-Like Receptors/metabolism , Epigenesis, Genetic , NF-kappa B/metabolism
3.
Genes Dev ; 34(21-22): 1474-1492, 2020 11 01.
Article in English | MEDLINE | ID: mdl-33060136

ABSTRACT

Macrophages polarize into functionally distinct subtypes while responding to microenvironmental cues. The identity of proximal transcription factors (TFs) downstream from the polarization signals are known, but their activity is typically transient, failing to explain the long-term, stable epigenomic programs developed. Here, we mapped the early and late epigenomic changes of interleukin-4 (IL-4)-induced alternative macrophage polarization. We identified the TF, early growth response 2 (EGR2), bridging the early transient and late stable gene expression program of polarization. EGR2 is a direct target of IL-4-activated STAT6, having broad action indispensable for 77% of the induced gene signature of alternative polarization, including its autoregulation and a robust, downstream TF cascade involving PPARG. Mechanistically, EGR2 binding results in chromatin opening and the recruitment of chromatin remodelers and RNA polymerase II. Egr2 induction is evolutionarily conserved during alternative polarization of mouse and human macrophages. In the context of tissue resident macrophages, Egr2 expression is most prominent in the lung of a variety of species. Thus, EGR2 is an example of an essential and evolutionarily conserved broad acting factor, linking transient polarization signals to stable epigenomic and transcriptional changes in macrophages.


Subject(s)
Cell Polarity/genetics , Early Growth Response Protein 2/genetics , Early Growth Response Protein 2/metabolism , Epigenesis, Genetic/genetics , Macrophages/cytology , STAT6 Transcription Factor/metabolism , Transcriptional Activation/genetics , Animals , Chromosome Mapping , Conserved Sequence , Enhancer Elements, Genetic/genetics , Gene Expression Regulation/genetics , Genome/genetics , Humans , Interleukin-4/metabolism , Macrophages/physiology , Mice , Mice, Inbred C57BL , Protein Interaction Domains and Motifs/genetics , STAT6 Transcription Factor/genetics , Transcriptome/genetics
4.
Mol Cell Endocrinol ; 471: 63-74, 2018 08 15.
Article in English | MEDLINE | ID: mdl-28774779

ABSTRACT

Macrophages are able to differentiate into classically polarized (M1) or alternatively polarized (M2) states upon encountering pro-inflammatory cytokines such as interferon (IFN) γ or anti-inflammatory cytokines such as interleukin (IL) -4/IL-13, respectively. Moreover, macrophages are known to regulate lipid metabolism via multiple members of the nuclear hormone receptor family, including the retinoid X receptors (RXR). It has been also documented that cytokines are able to modulate macrophage responses to lipid signals but the nature of these interactions and the underlying mechanisms of these processes especially at the level of the chromatinized genome are not well understood. Previous work from our laboratory suggested that STAT6 is a facilitator of nuclear receptor mediated transcriptional activity acting at the genome level. This prompted us to investigate genome-wide DNA binding events and the development of cistromes in human CD14+ monocyte-derived macrophages upon exposure to IL-4. We determined the impact of IL-4 on the PU.1, RXR and STAT6 cistromes within the active enhancer regions marked by H3K27-acetylation using chromatin immunoprecipitation followed by deep sequencing and integrated bioinformatics analyses. We found that about 2/3rd of the IL-4 induced STAT6 peaks co-localized with RXR peaks. These STAT6/RXR co-peaks differed at least in part from the non-overlapping RXR peaks regarding the most enriched de novo transcription factor binding motifs. Interestingly, RXR-binding was not regulated at the STAT6/RXR co-bound enhancers following IL-4 stimulation, but differential enhancer interactions were observed between the IL-4/STAT6 and RXR signaling pathways acting in a gene selective manner. Our results suggest that there is a novel, so far uncharacterized cistromic crosstalk between RXR and STAT6 that is likely to contribute to the formation of the active enhancer repertoire, transcriptome and differential signal-specific gene regulation of polarized macrophages.


Subject(s)
Cell Differentiation , Enhancer Elements, Genetic/genetics , Lipopolysaccharide Receptors/metabolism , Macrophages/cytology , Monocytes/metabolism , Retinoid X Receptors/metabolism , STAT6 Transcription Factor/metabolism , Cells, Cultured , Gene Expression Profiling , Genome, Human , Humans , Interleukin-4/metabolism , Macrophages/metabolism , Protein Binding , Proto-Oncogene Proteins/metabolism , Signal Transduction , Trans-Activators/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...